CB2 Insights is a consolidator of US-based medical cannabis patient evaluation clinics, and CB2 expects to continue to do this for the next several years. After buying clinics CB2 is able to enhance revenues and margins while reducing churn. But this is not the reason for its consolidation strategy – CB2 is building a data lake from patients it manages, with a longer term objective of monetizing the data in analytics tools it plans to license to medical cannabis producers and big pharma.

Watch video HERE.